Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Breaking the Barrier in Stroke: What Should we Know? A Mini-Review

Author(s): Cesar V. Borlongan, Antonio A. Rodrigues and Maria Carolina Oliveira

Volume 18, Issue 25, 2012

Page: [3615 - 3623] Pages: 9

DOI: 10.2174/138161212802002670

Price: $65

Open Access Journals Promotions 2
Abstract

The blood-brain barrier (BBB) has been considered as an important regulator of brain homeostasis, and its disturbance has been implicated in the onset and/or evolution of many pathological manifestations of neurodegenerative and inflammatory diseases [1, 2]. In particular, BBB breakdown has been closely associated with the primary insult, as well as the secondary cell death of stroke. Here, we review the pioneering contributions of leading scientists who have vested interest in advancing our understanding of the pivotal role of BBB in stroke, but also exploiting this knowledge in developing novel BBB-based therapeutic regimens to abrogate stroke symptoms. The study of BBB as a fundamental research theme and as a target for clinical applications in stroke can be approached in three main themes namely, basic science research, translational and clinical research, and emerging therapies for BBB repair in stroke. This minireview captures cutting-edge discoveries establishing BBB as a central target for abetting neuroprotection and neurorestoration in stroke.

Keywords: Cerebral ischemia, central nervous system, permeability, bioavailability, pathology, therapy, blood-brain barrier (BBB), brain homeostasis, inflammatory diseases, stroke.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy